This First-of-Its-Kind Hair Growth Peptide Promises Results in 6 Days — 5 Months Later, I'm Stunned
Four months after having my baby, I was partially convinced someone had made a voodoo doll of me and was ripping out my strands in sizable, gasp-worthy clumps. I left behind dark wads of hair in the shower, sink, bed, and even in my daughter's mighty little fists. 'You gotta stop ripping out what's left of Mama's hair,' I joked with my baby. On the inside, I started panicking. How much more hair will I shed? Will it ever end?
'Postpartum hair loss is a result of estrogen levels that were high during pregnancy suddenly dropping,' BosleyMD trichologist Gretchen Friese tells Flow Space. 'Because estrogen levels are so high during pregnancy, the hair can seem thicker and then when it starts falling out it can feel like a lot of hair.' Postpartum isn't the only time in a woman's life when she can experience hair loss and shedding due to estrogen fluctuation: This can also occur in perimenopause and menopause as the ovaries produce less estrogen.
While I knew this was just par for the course, I still didn't like it. So I tried eating more steak for the iron (expensive), took Nutrafol every day (so many pills), and swapped in thickening shampoos (this works but it doesn't give you permanent results). And then I found OMI.
OMI Hair Growth Peptide Gummies (120-Day Supply)
Buy Now at omi $79
Buy Now On Amazon $79.00
OMI hair peptides, which you can get in gummy or pill form (I chose gummy, since they taste like candy), are formulated by a patented hair technology (IFP Hair Factor) that improves hair follicle health. OMI Hair Growth Peptides 'directly target hair follicles to strengthen and anchor hair from within,' founder of OMI, Naomi Whittel, tells Flow Space. 'Unlike nutritional supplements, which provide the body with essential vitamins and minerals to support overall hair health, peptides work as a key, unlocking the ability of hair follicles to repair and rebuild.' Think of it as a laser-focused formulation that cuts to the chase when it comes to hair health and regrowth—for any kinds of hair loss, too, not just postpartum.
OMI's formulation also includes biotin (also known as vitamin B7), and a cocktail of other B vitamins (B6, B3 or niacin, and B5 or pantothenic acid) that supercharge amino acids, which leads to healthier hair.
'While natural solutions like rosemary oil focus on improving scalp health externally, OMI's peptide-based formula works at the follicular level, directly addressing the structural needs of hair to restore integrity, combat postpartum shedding, and support healthy regrowth,' Whittel says. Within 90 days, people with all hair types will notice stronger, thicker hair. The tech is so powerful, OMI promises results in just six (!!!) days, though recommends staying the course for the full 90 days. I decided to put it to the test and see if it would help with my sad post-pregnancy hair.
I've been taking OMI gummies for five months (updated), and so far, I'm impressed. It's not that the results have been instant regrowth (I think we can all be realistic here), but I've witnessed far less shedding. This, in turn, has made my hair look a lot fuller than it has been in the last couple months. When I wring my hair in the shower, I'm not also pulling out a wad of strands. My sink isn't hairy. When my daughter grabs my hair, she isn't able to easily yank it all out. I don't feel personally victimized by my brush anymore. The results have been fairly quick, but I do plan on taking the gummies for the full 90 days, so bookmark this page if you want to follow along!
I took a 'before' photo the day before I started taking OMI, and another photo this morning (18 days had passed). I was worried you wouldn't be able to really tell just how thin my hair had become, but looking at these photos side by side, I'm legitimately shook. You can visually see how much fuller my ponytail looks today compared to how damaged and frail-looking it appeared only weeks ago.
I documented my hair brush after a few of the showers I took as well. That's when (and where) I'd notice the most fallout. Day 1 you can see that the brush is pretty packed with my hair (RIP). Day 5 and Day 10 have remarkably less hair (it looks like Day 5 has more hair, but it probably has the same amount).
And here, you can really see the difference. This is the amount of hair I pulled from the brush each time I took photos.
I took OMI gummies, but you can take a pill form, too. Maybe this is childish, but I'm far more likely to take a supplement if it tastes like a Sour Patch Kid (OMI tastes like blackberries). I've been pretty good about taking two every day after breakfast because they actually taste good.
I've been religiously taking OMI gummies and capsules for a total of five months now, and my hair legitimately feels thicker (when I put it in a ponytail, I'm pleasantly surprised when I don't have to wrap the hair tie around a bunch of times), and new hair is visibly growing at my temples.
Here's a photo of me and my daughter. My hair just LOOKS healthier, too.
I've also noticed far less hair a) in the shower, and b) in my brush post-shower. There's definitely been less fall-out and more hair growth (albeit in baby hair form!). The progress is slow, but I can see and feel the difference. I'll be sure to report back in the next three months so we can compare with the above photo.
I do have to give some credit to my shampoo and conditioner: I've been using the Aveda Invati Ultra Advanced line, and I think it's really helped my hair appear fuller and shinier. I've been using Aveda products since I was a literal kid (my uncle is a hair stylist and has been doing my hair since I was baby), so I really trust the brand.
Aveda Ultra Advanced Shampoo & Conditioner Set
$73 Buy Now
I've also been using Briogeo Scalp Revival Rosemary Pre-Wash Scalp & Hair Oil before showering as a scalp 'mask' of sorts. I'll apply it all over and let it sit for about 15 to 20 minutes and then shower. I think it helps moisturize my scalp and keep it healthy (which is especially helpful during weeks I end up using a lot of dry shampoo and hairspray, which can dry out the scalp), which in turn aids with growth.
Briogeo Scalp Revival™ Rosemary Pre-Wash Scalp and Hair Oil
$32 Buy Now
'Get enough sleep, keep stress levels at bay and eat a healthy diet full of good fats and stay away from processed sugars,' Dr. Friese recommended when I asked about any other measures that could be taken when trying to prevent more shedding. Easier said than done when you're a new mom, but with OMI and some good haircare, I have the tricks up my sleeve to be well on my way to my pre-baby hair.
More from Flow Space
Can Tea Ease Menopause Symptoms? I Tried Magic Hour's Divine Timing Collection to Find Out
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
42 minutes ago
- Fox News
Body fat predicts major health risk that BMI misses, researchers say
Body mass index (BMI) may not be the most accurate predictor of death risk. A new study from the University of Florida found that BMI — a measurement that is commonly used to determine whether a person's weight is in a healthy range for their height — is "deeply flawed" in terms of predicting mortality. Instead, one's level of body fat is "far more accurate," concluded the study, which was published this week in the Annals of Family Medicine. To measure participants' body fat, the researchers used a method called bioelectrical impedance analysis (BIA), which uses a device to measure the resistance of body tissue to a small electrical current. Over a 15-year period, those who had high body fat were found to be 78% more likely to die than those who had healthy body fat levels, researchers found. They were also more than three times as likely to die of heart disease, the study noted. BMI — which is calculated by dividing weight by height, squared — was described as "entirely unreliable" in predicting the risk of death over a 15-year period from any cause. The study included 4,252 people in the U.S. and pulled data from the National Health and Nutrition Examination Survey. BMI should not be relied upon as a "vital sign" of health, according to senior author Frank Orlando, M.D., medical director of UF Health Family Medicine in Springhill. "I'm a family physician, and on a regular basis, we're faced with patients who have diabetes, heart disease, obesity and other conditions that are related to obesity," Orlando said in a press release for the study. "One of the routine measures we take alongside traditional vital signs is BMI. We use BMI to screen for a person having an issue with their body composition, but it's not as accurate for everyone as vital signs are," he added. BMI has been the international standard for measuring obesity since the 1980s, according to many sources, though some experts have questioned its validity. "I think the study shows it's time to go to an alternative that is now proven to be far better at the job." An individual is considered obese if their BMI is 30 or above, overweight if it is between 25 and 29.9, of "normal" weight in the range of 18.5 to 24.9, or underweight if lower than 18.5. While BMI is easy to calculate, one of its main limitations is that it cannot distinguish between muscle and fat mass, the researchers noted. "For example, people who are bodybuilders can really elevate their body mass index," Orlando said. "But they're healthy even with a BMI indicating that they're obese." "BMI is just so ingrained in how we think about body fat," Mainous added. "I think the study shows it's time to go to an alternative that is now proven to be far better at the job." Other methods, such as a DEXA (dual-energy X-ray absorptiometry) scan, may be even more accurate than BIA, but are much more expensive and not as accessible, the researchers noted. "If you talk to obesity researchers, they're going to say you have to use the DEXA scan because it's the most accurate," Mainous said in the release. "And that's probably true. But it's never going to be viable in a doctor's office or family practice." Dr. Stephen Vogel — a family medicine physician with PlushCare, a virtual health platform with primary care, therapy and weight management options — echoed the limitations of BMI. "It has been an easy measurement tool that helps us understand at-risk groups across various populations and demographics, but it doesn't provide accurate data from patient to patient," the North Carolina-based doctor, who was not involved in the study, told Fox News Digital. "These findings don't challenge the assumptions about BMI — they strengthen the message that new standards, delivered in a consistent and low-cost way, would provide better nuance for the individual when it comes to their overall physical health." "The main strengths of this study are a better correlation to an individual's risk of morbidity and mortality — however, the limitations lie in the fact that we don't have enough data to determine the right cutoff for these numbers, or to identify the right tools that will be both accurate and precise across the population," Vogel said. The researchers also acknowledged that body fat percentage thresholds haven't yet been as standardized as BMI and waist circumference. Also, the age range of the participants in the study was limited by the data source. "Future studies should extend this comparison of body fat to BMI in older adults," the researchers wrote. The study was also limited by focusing only on mortality as an outcome, they noted, without taking into account any developing diseases — such as heart failure or cancer — that could deepen the understanding of body fat as a risk factor. The goal, according to Vogel, is to have a cost-effective, consistent method that can be used across the population with reliable accuracy. "These data will drive better discussions in the doctor's office, as well as public health initiatives with the goal of improving the health of all." "Benefits would come in the form of a more detailed list of information that helps providers and patients make informed decisions about the patient's health, which is ideal," Vogel noted. "I'm hopeful there's enough buzz around these measures that steps will continue to be taken toward regular implementation." For more Health articles, visit The researchers are hopeful that once standards are validated, measuring body fat percentage with bioelectrical impedance analysis could become standard of care. They added, "These data will drive better discussions in the doctor's office, as well as public health initiatives with the goal of improving the health of all."
Yahoo
an hour ago
- Yahoo
Citi Expresses Optimism for Eli Lilly and Company (LLY)
Eli Lilly and Company (NYSE:LLY) is one of the 13 Best Long Term Growth Stocks to Invest in Right Now. On June 25, Citi reported that 'compelling' data shows that Eli Lilly and Company (NYSE:LLY) and Novo Nordisk (NVO) have turned obesity into a treatable disease from a lifestyle-based condition. The firm models more than $40 billion in obesity sales by 2030, well above the consensus estimates of $25 billion. Citi stated that as the obesity space evolves from injectables to convenient orals, such as orforglipron, the emergence of a 'dynamic' consumer-centric market is possible, and LillyDirect by Eli Lilly and Company (NYSE:LLY) is well-positioned to connect high consumer visibility for orforglipron with global access. In a research note, Citi further stated that it estimated penetration rates via income-based tiers for pricing and out-of-pocket costs in low- and mid-body mass index patients. The results place Eli Lilly and Company's (NYSE:LLY) consumer platform opportunity at $15B, which is not assumed in the firm's model. It thus believes that Eli Lilly and Company's (NYSE:LLY) is in a position to expedite access outside the US, employing a centralized out-of-pocket payment model instead of the traditional country-by-country launch. It contended that an 'income-based tiered pricing of orforglipron via LillyDirect could unlock unprecedented volume, all the while allowing it to maintain overall pricing power.' Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span oncology, diabetes, immunology, neuroscience, and other therapies. Investors are bullish on Eli Lilly and Company (NYSE:LLY) due to its in-demand GLP-1 drugs, used to treat diabetes and obesity, which are still in their early growth stages, and the company's strong financials. While we acknowledge the potential of LKQ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Sign in to access your portfolio
New York Times
an hour ago
- New York Times
Why a G.O.P. Medicaid Requirement Could Set States Up for Failure
The strict Medicaid work requirement at the center of the Republicans' major policy bill wouldn't just require millions of poor Americans to prove they are employed to sign up for health insurance. It would also require dozens of states to quickly build expensive and complex software systems to measure and track who is eligible. This new responsibility for states, whose existing Medicaid computer systems are often outdated, would be accompanied by reduced federal funding through other changes in the bill. The result, according to state officials, software developers and policy experts, could be major failures in state systems for enrolling people in Medicaid. 'That's how happens,' said Julie Brinn Siegel, a former top Biden administration budget official, referring to the Obama administration's botched launch of the online Affordable Care Act enrollment portal in 2013. Ms. Siegel and others familiar with Medicaid systems envision problems like websites that don't load or incorrectly tell applicants they are not eligible. And Medicaid workers may be overwhelmed as they try to run call centers and process applications. The fallout could mean eligible Americans will have their coverage dropped. Republicans contend that the work requirement achieves twin goals: It ensures that the government directs resources to Americans who are contributing to society, while saving money to help finance an extension of President Trump's tax cuts. Want all of The Times? Subscribe.
